The present invention relates to compounds of formula (I); which are capable of inhibiting the 11-beta-hydroxysteroid dehydrogenase type 1 (11- beta-HSD1), to processes for preparing these compounds, to pharmaceutical compositions comprising an effective amount of these compounds, to the use of the compounds in medicine in particular for the treatment of pathological conditions or diseases that can improve by inhibition of 11-beta-HSD1, to the use of said compound for the manufacture of a medicament for the treatment of pathological conditions or diseases that can improve by inhibition of 11-beta-HSD1 and to methods for the treatment or prevention of a disease or conditions susceptible of improvement by inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11β-HD1) in a subject in need thereof comprising the administration to said subject of a therapeutically effective amount of said compounds.
本发明涉及式(I)的化合物,该化合物能够抑制11-β-羟基类
固醇脱氢酶1型(11-β-H
SD1),涉及制备这些化合物的方法,包括这些化合物的有效量的药物组合物,将这些化合物用于医学,特别是用于治疗通过抑制11-β-H
SD1可以改善的病理状况或疾病,将所述化合物用于制造用于治疗通过抑制11-β-H
SD1可以改善的病理状况或疾病的药物,以及用于治疗或预防需要的受试者中通过抑制11β-羟基类
固醇脱氢酶1型(11β-HD1)可以改善的疾病或病症的方法,包括向该受试者施用所述化合物的治疗有效量。